Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Teleflex Life Sciences Unlimited Company company patent portfolio operates within the Medical Devices & Mechanical Engineering technology area. Current prosecution activity is characterized by 1 pending office action, which is distributed across 1 distinct examiner and 1 distinct art unit. This concentration suggests a focused technical scope for the entity's intellectual property development.
The busiest examiner for this portfolio is STRACHAN, KATE ELIZABETH, who is currently managing 1 busiest examiner pending office action. Since there is 1 pending office action in total, STRACHAN, KATE ELIZABETH is responsible for the entirety of the active prosecution workload. This activity is localized within 1 distinct art unit, indicating that the legal strategy is confined to a specific niche within the Medical Devices & Mechanical Engineering sector.
Practitioners should note that with only 1 distinct examiner involved, the outcome of the current pending office action will significantly impact the overall success of the portfolio. The alignment of 1 pending office action with 1 distinct art unit reflects a streamlined interaction with the patent office. This approach allows for a dedicated focus on securing specific assets without the complexity of multiple simultaneous examinations.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STRACHAN, KATE ELIZABETH | 1 | 49.6% | +31.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17525946 | CATHETER ASSEMBLY | STRACHAN, KATE ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 3781 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17525946 | CATHETER ASSEMBLY | STRACHAN, KATE ELIZABETH | 3781 | §103 | Non-Final OA | — | Pending | Nov 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTeleflex Life Sciences Unlimited Company has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kate Elizabeth Strachan has the most, with 1 of Teleflex Life Sciences Unlimited Company's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
